RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1982; 47(02): 189
DOI: 10.1055/s-0038-1657163
DOI: 10.1055/s-0038-1657163
Letter to the Editor
Platelets, Cardiac Valves and Sulphinpyrazone
Weitere Informationen
Publikationsverlauf
Received 18. Januar 1982
Accepted 23. Februar 1982
Publikationsdatum:
13. Juli 2018 (online)
-
References
- 1 Ludlam CA, Allan N, Blandford RB, Dowdle R, Bentley NJ, Bloom AL. Platelet and coagulation function in patients with abnormal cardiac valves treated with Sulphinpyrazone. Thromb Haemostas 1981; 46: 743-746
- 2 Blackburn EK. Long-term anticoagulant therapy. Prescribers’ J 1976; 16: 73-74
- 3 Barkhan P. Therapeutic range with BCTR (letter). Thromb Haemostas 1976; 35: 751
- 4 Loeliger EA. The optimal therapeutic range in oral anticoagulation. History and Proposal. Thromb Haemostas 1979; 42: 1141-1152
- 5 Steele P, Rainwater J. Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease. Circulation 1980; 62: 462-465
- 6 Loeliger EA. Sulfinpyrazone and Thromboembolism (letter). Circulation 1981; 64: 1076-1077